Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-18-0653
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Thrombotic Microangiopathy With Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma

Case Reports in Oncology
Oncology
2018English

Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma

JAMA - Journal of the American Medical Association
Medicine
2000English

Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Medicine
Medicine
2019English

RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

Radioactive Iodine Ablation May Not Decrease the Risk of Recurrence in Intermediate-Risk Papillary Thyroid Carcinoma

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer

Cancer
Cancer ResearchOncology
2017English

P298 Thyroid Cancer Patient’s Fertility After Radioactive Iodine Therapy

2019English

Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy